The Enterprise Value as of November 2025 (TTM) for Inozyme Pharma, Inc. (INZY) is 279.36M

According to Inozyme Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 279.36M. This represents a change of 19.23% compared to the average of 234.30M of the last 4 quarters.

Inozyme Pharma, Inc. (INZY) Historical Enterprise Value (quarterly & annually)

How has INZY Enterprise Value performed in the past?

The mean historical Enterprise Value of Inozyme Pharma, Inc. over the last ten years is 196.39M. The current 279.36M Enterprise Value has changed 14.12% with respect to the historical average. Over the past ten years (40 quarters), INZY's Enterprise Value was at its highest in in the March 2024 quarter at 477.57M. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Inozyme Pharma, Inc. (INZY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Inozyme Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Inozyme Pharma, Inc. (INZY) Average Enterprise Value

How has INZY Enterprise Value performed in the past?

The current Enterprise Value of Inozyme Pharma, Inc. (INZY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Inozyme Pharma, Inc. (INZY) Enterprise Value vs. Peers

How is INZY’s Enterprise Value compared to its peers?

Inozyme Pharma, Inc.’s Enterprise Value is greater than Third Harmonic Bio, Inc. (-25821436.00), greater than Acelyrin, Inc. (176.86M), greater than Alaunos Therapeutics, Inc. (6.07M), greater than Spectrum Pharmaceuticals, Inc. (199.44M), less than scPharmaceuticals Inc. (313.84M), less than 2seventy bio, Inc. (413.55M), greater than CARGO Therapeutics, Inc. Common Stock (109.02M), less than LakeShore Biopharma Co., Ltd (631.04M), greater than Vaccitech plc (-33263316.00), greater than Catabasis Pharmaceuticals, Inc. (163.31M),

Build a custom stock screener for Inozyme Pharma, Inc. (INZY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inozyme Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Inozyme Pharma, Inc. (INZY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Inozyme Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.